Health Care & Life Sciences » Pharmaceuticals | Aralez Pharmaceuticals Inc.

Aralez Pharmaceuticals Inc.

Aralez Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
66.97 M
Public Float
-
Aralez Pharmaceuticals Inc.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD2.26
Market Cap
CAD2.23 M
Shares Outstanding
66.97 M
Public Float
-

Profile

Address
7100 West Credit Avenue
Mississauga Ontario L5N 0E4
Canada
Employees -
Website http://www.aralez.com
Updated 09/14/2018
Aralez Pharmaceuticals Inc. focuses on the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. It operates through the foolowing geographical segments: United States, and Canada. The company is founded on December 2, 2015 and is headquartered in Ontario, Canada.

Financials

View All
Created with Highcharts 5.0.14Aralez Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.16 70816 70819 67419 67437 78337 783102 978102 978125 205125 20520132014201520162017025k50k75k100k125k150k
Created with Highcharts 5.0.14Aralez Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.10 32210 32232 39432 39421 39121 39154 27054 270105 947105 94720132014201520162017025k50k75k100k125k

Adrian Adams
Chief Executive Officer & Director
Robert Paul Harris
Director